Jessica Crespo - 18 Mar 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
CAO/SVP, Finance
Signature
Jessica Crespo
Issuer symbol
OCGN
Transactions as of
18 Mar 2022
Net transactions value
$0
Form type
4
Filing time
22 Mar 2022, 18:45:45 UTC
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Award $0 +22,940 +131% $0.000000 40,440 18 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +84,192 $0.000000 84,192 18 Mar 2022 Common Stock 84,192 $3.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Ocugen, Inc's (the "Company's") common stock. The restricted stock units vest annually in three equal installments commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates. The restricted stock units will be settled on each applicable vesting date in shares of the Company's common stock.
F2 The option vests annually in equal installments over three years commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates.